As per Sebi's T+1 settlement cycle, investors must buy the company's shares at least one trading day before the record date for them to be ...

Indian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC face...

The Delhi High Court has issued a temporary restraining order against the NPPA's actions toward AstraZeneca Pharma. This order remains in e...

Indian equities experienced a strong start to the week, bolstered by better than expected Q2 earnings. Improved domestic macro indicators c...

Stock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...

Stock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...

Over the past four quarters, India's medicine sales have increased significantly due to rising demand in chronic care segments. The growth ...

The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...

This is the time to focus on businesses that have lived through storms like this before and come out the other side. The large, proven name...

Sun Pharmaceutical Industries experienced a significant decline in net profit during the September quarter of FY27. The company incurred ac...

The Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...

One stock not falling on bad news does not mean the worst is over for the whole market. It may mean only that the bears have, for now, take...

When a market is as jittery as it is right now, poor numbers are treated harshly. A new-age company in the business of buying and selling u...

Indian markets closed lower on Wednesday as rising crude oil prices and Middle East tensions hurt sentiment. Sensex fell 353 points to 73,2...

Dalal Street faces significant market challenges, leading Kotak Institutional Equities to spotlight selective stock value. With large-cap s...

Mankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...

The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of...